Tarsus Pharmaceuticals, Inc. (TARS) Insider Ownership

Historic Insider Ownership Trends

TARS's three largest insider shareholders as of June 18, 2026 are Capital Ix, Llc Vivo (TenPercentOwner, 2.47Mn shares), Michael Ackermann (Director, 1.21Mn shares), Bobak R. Azamian (President/Ceo And Board Chair, 857.99K shares).

Top Direct Holders

Insider ownership data is derived from the last 60 months of Form 4 SEC filings.
Holder Position Shares (Direct) Shares (Indirect) Report Date
Wendy L Yarno - 13,700 0 16 Jun, 2025
William J Phd Link - 116,332 0 18 Mar, 2026
Jeffrey S Farrow - 43,316 0 19 Mar, 2026
Rosemary A Crane - 5,350 0 25 Jun, 2024
Bhaskar Chaudhuri - 8,700 0 16 Jun, 2025
Leonard M. Greenstein Chief Financial Officer 26,785 0 21 Apr, 2023
Jose M. Trevejo Chief Medical Officer 2,251 0 22 Dec, 2023
Scott W Morrison - 4,684 0 16 Sep, 2025
Capital Ix, Llc Vivo - 0 2,469,001 05 May, 2022
Aziz Mottiwala Chief Commercial Officer 61,480 0 19 Mar, 2026
Michael Ackermann - 1,208,273 0 17 Jun, 2022
Mark J. Holdbrook V.P., Clinical Affairs 3,191 0 21 Mar, 2023
Seshadri Neervannan Chief Operating Officer 82,791 0 24 Mar, 2026
Bobak R. Azamian President/Ceo And Board Chair 0 857,991 30 Dec, 2025
Andrew D. Goldberg - 16,700 0 16 Jun, 2025
Dianne C. Whitfield Chief Human Resources Officer 35,028 0 19 Mar, 2026
Bryan Wahl General Counsel 63,959 0 19 Mar, 2026
Elizabeth Yeu Lin Chief Medical Officer 23,308 0 19 Mar, 2026
Katherine Goodrich - 2,233 0 14 Jan, 2026

* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.

Recent Insider Transactions

Detailed insider trading activity based on Form 4 SEC filings.
Download Data
Transaction Date Insider Name Security Class Transaction Type Shares Traded Price Shares Remaining Ownership Code
20 Mar, 2026 Seshadri Neervannan Common Stock D 2,989 $66.75 82,791 D S
17 Mar, 2026 Dianne C. Whitfield Common Stock D 4,029 $69.42 43,273 D S
17 Mar, 2026 Jeffrey S Farrow Common Stock D 2,111 $69.42 47,635 D S
17 Mar, 2026 Bryan Wahl Common Stock D 4,084 $69.42 72,315 D S
17 Mar, 2026 Seshadri Neervannan Common Stock D 3,125 $69.42 93,979 D S
17 Mar, 2026 Dianne C. Whitfield Common Stock D 4,029 $69.42 43,273 D S
17 Mar, 2026 Bryan Wahl Common Stock D 4,084 $69.42 72,315 D S
17 Mar, 2026 Elizabeth Yeu Lin Common Stock D 375 $69.42 24,077 D S
17 Mar, 2026 Aziz Mottiwala Common Stock D 4,286 $69.42 70,250 D S
17 Mar, 2026 Bobak R. Azamian Common Stock D 10,972 $69.42 57,052 D S
18 Mar, 2026 Seshadri Neervannan Common Stock D 3,610 $68.71 90,369 D S
18 Mar, 2026 Aziz Mottiwala Common Stock D 4,330 $68.71 65,920 D S
18 Mar, 2026 Bobak R. Azamian Common Stock D 11,667 $68.71 45,385 D S
18 Mar, 2026 Bryan Wahl Common Stock D 4,125 $68.71 68,190 D S
18 Mar, 2026 Dianne C. Whitfield Common Stock D 4,071 $68.71 39,202 D S
18 Mar, 2026 Elizabeth Yeu Lin Common Stock D 379 $68.71 23,698 D S
18 Mar, 2026 Jeffrey S Farrow Common Stock D 2,133 $68.71 45,502 D S
18 Mar, 2026 Bryan Wahl Common Stock D 4,125 $68.71 68,190 D S
18 Mar, 2026 Dianne C. Whitfield Common Stock D 4,071 $68.71 39,202 D S
19 Mar, 2026 Bryan Wahl Common Stock D 4,231 $67.00 63,959 D S